Dec 23, 2021

Northborne Transaction Announcement | Riverwood Group Acquired by BayMark

MINNEAPOLIS, MN, December 23, 2021 – Northborne Partners acted as the exclusive financial advisor to Riverwood Group, LLC (“Riverwood”) in its sale to BayMark Health Services (“BayMark”). The transaction closed on December 22, 2021; financial terms were not disclosed.

Riverwood is a leading provider of medication-assisted treatment (MAT), offering the highest levels of care for those struggling with opioid use disorder. Their Opioid Treatment Programs (OTP) provide treatment for opioid addiction with methadone supported by substance use counseling and wrap-around treatment services. The staff of all 13 programs in Arkansas, Florida, Illinois, Indiana, Kansas, Nebraska and South Dakota will continue their dedicated work under BayMark’s experienced leadership team.

BayMark OTPs across the country provide medically-supervised, medication-assisted treatment utilizing methadone, buprenorphine and long-acting naltrexone supported by counseling and other psychosocial services. Those services include addiction education, relapse prevention, in-house lab testing, coordinated care for pregnant women and linkages to critical community resources. BayMark’s mission to foster wellness, longevity and socially responsible behavior for the patients it serves is shared by Riverwood.

David K. White, Ph.D., Chief Executive Office of BayMark Health Services noted, “BayMark has decades of experience in treating the disease of addiction and looks to work with organizations who share our foundation of quality care and compassion. We look forward to working with the exceptional Riverwood staff who have made their patients the priority as COVID-19 changed the landscape of treatment while opioid use and other drug use increased across the country.”

The Riverwood transaction represents Northborne’s third closed transaction in the substance use disorder market in 2021.

About Northborne Partners

Northborne Partners is a preeminent middle market investment banking firm focused on providing M&A advisory services to companies in the food & consumer, healthcare and industrials sectors, among others. It focuses on advising private business owners in the sale of their companies and has decades of experience sitting across the table from the most seasoned strategic and private equity buyers in the world. Northborne Partners is headquartered in Minneapolis, MN. For more information, please visit www.northborne.com.

About Riverwood Group

Riverwood is a leading provider of medication-assisted treatment, offering the highest levels of care for those struggling with opioid use disorder. Riverwood operates 13 opioid treatment programs across seven states (Arkansas, Florida, Illinois, Indiana, Kansas, Nebraska and South Dakota) and provides treatment for opioid addiction through methadone MAT, supported by substance use counseling and wrap-around treatment services. For more information, please visit http://www.methadonetreatmentcenter.com/.

About BayMark Health Services

BayMark Health Services provides Substance Use Disorder (SUD) treatment to 70,000+ patients in recovery across more than 300 treatment facilities in 35 states and 3 Canadian provinces. The largest provider of Opioid Use Disorder (OUD) services in North America and the leader in evidence-based treatment options for SUD’s, BayMark’s continuum of care includes medication-assisted treatment (MAT), withdrawal management, counseling and other innovative support therapies in outpatient, inpatient and residential settings. For more information, please visit https://BayMark.com/.

Website includes transactions completed by Northborne professionals at prior firms.

Contact us to find out how Northborne can drive value and increase the probability of success of your transaction.

Address

212 3rd Ave N, Suite 400
Minneapolis, MN 55401

© 2022 Northborne Partners LLC